Uncovering the molecular drivers of B-cell lymphoma tumor growth
Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...
News Medical on MSN15d
Researchers identify key factors for successful donor lymphocyte infusion in AML patients
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...
Nature6d
Fcα/μ receptor mediates endocytosis of IgM-coated microbes
Fcα/μR is constitutively expressed on the majority of B lymphocytes and macrophages. Cross-linking Fcα/μR expressed on a pro-B cell line Ba/F3 transfectant with soluble IgM or IgM-coated ...
Hosted on MSN20d
AstraZeneca secures first BTK approval in first-line mantle cell lymphoma
MCL is a rare and aggressive subtype of non-Hodgkin lymphoma, often diagnosed in later stages and characterised by the malignant transformation of B lymphocytes in the ... first BTK approval in ...
Nature4y
Iovance unleashes natural-born killers: tumor-infiltrating lymphocytes
Lymphocytes, notably T cells, are capable of killing cancer cells ... and similar manufacturing capabilities are set to come on line in Europe in the near future. The ‘first generation ...
I Peace establishes and offers low immunoreaction risk GMP iPS Cells
Leading GMP cell CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the company has established low immunoreaction risk GMP ...